KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aquestive Therapeutics (AQST) Tax Provisions (2023 - 2024)

Historic Tax Provisions for Aquestive Therapeutics (AQST) over the last 2 years, with Q4 2024 value amounting to -$14000.0.

  • Aquestive Therapeutics' Tax Provisions fell 11386.14% to -$14000.0 in Q4 2024 from the same period last year, while for Mar 2025 it was -$14000.0, marking a year-over-year decrease of 10571.43%. This contributed to the annual value of -$14000.0 for FY2024, which is 10571.43% down from last year.
  • Aquestive Therapeutics' Tax Provisions amounted to -$14000.0 in Q4 2024, which was down 11386.14% from $101000.0 recorded in Q4 2023.
  • In the past 5 years, Aquestive Therapeutics' Tax Provisions ranged from a high of $284000.0 in Q2 2023 and a low of -$140000.0 during Q3 2023